These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28829151)

  • 1. Validation of an Immunohistochemistry Assay for Detection of CD155, the Poliovirus Receptor, in Malignant Gliomas.
    Chandramohan V; Bryant JD; Piao H; Keir ST; Lipp ES; Lefaivre M; Perkinson K; Bigner DD; Gromeier M; McLendon RE
    Arch Pathol Lab Med; 2017 Dec; 141(12):1697-1704. PubMed ID: 28829151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent Glioblastoma Treated with Recombinant Poliovirus.
    Desjardins A; Gromeier M; Herndon JE; Beaubier N; Bolognesi DP; Friedman AH; Friedman HS; McSherry F; Muscat AM; Nair S; Peters KB; Randazzo D; Sampson JH; Vlahovic G; Harrison WT; McLendon RE; Ashley D; Bigner DD
    N Engl J Med; 2018 Jul; 379(2):150-161. PubMed ID: 29943666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered Oncolytic Poliovirus PVSRIPO Subverts MDA5-Dependent Innate Immune Responses in Cancer Cells.
    Walton RW; Brown MC; Sacco MT; Gromeier M
    J Virol; 2018 Oct; 92(19):. PubMed ID: 29997212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polio virotherapy targets the malignant glioma myeloid infiltrate with diffuse microglia activation engulfing the CNS.
    Yang Y; Brown MC; Zhang G; Stevenson K; Mohme M; Kornahrens R; Bigner DD; Ashley DM; López GY; Gromeier M
    Neuro Oncol; 2023 Sep; 25(9):1631-1643. PubMed ID: 36864784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus receptor CD155-targeted oncolysis of glioma.
    Merrill MK; Bernhardt G; Sampson JH; Wikstrand CJ; Bigner DD; Gromeier M
    Neuro Oncol; 2004 Jul; 6(3):208-17. PubMed ID: 15279713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant Poliovirus for Cancer Immunotherapy.
    Gromeier M; Nair SK
    Annu Rev Med; 2018 Jan; 69():289-299. PubMed ID: 29414253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytotoxic and immunogenic mechanisms of recombinant oncolytic poliovirus.
    Brown MC; Gromeier M
    Curr Opin Virol; 2015 Aug; 13():81-5. PubMed ID: 26083317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma.
    Lupo KB; Matosevic S
    J Hematol Oncol; 2020 Jun; 13(1):76. PubMed ID: 32532329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poliovirus Receptor (CD155) Expression in Pediatric Brain Tumors Mediates Oncolysis of Medulloblastoma and Pleomorphic Xanthoastrocytoma.
    Thompson EM; Brown M; Dobrikova E; Ramaswamy V; Taylor MD; McLendon R; Sanks J; Chandramohan V; Bigner D; Gromeier M
    J Neuropathol Exp Neurol; 2018 Aug; 77(8):696-702. PubMed ID: 29878245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Practical Consideration of Poliovirus as an Oncolytic Virotherapy.
    Denniston E; Crewdson H; Rucinsky N; Stegman A; Remenar D; Moio K; Clark B; Higginbotham A; Keffer R; Brammer S; Horzempa J
    Am J Virol; 2016; 5(1):1-7. PubMed ID: 28203321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptors for hyaluronic acid and poliovirus: a combinatorial role in glioma invasion?
    Maherally Z; Smith JR; An Q; Pilkington GJ
    PLoS One; 2012; 7(2):e30691. PubMed ID: 22363471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncolytic treatment and cure of neuroblastoma by a novel attenuated poliovirus in a novel poliovirus-susceptible animal model.
    Toyoda H; Yin J; Mueller S; Wimmer E; Cello J
    Cancer Res; 2007 Mar; 67(6):2857-64. PubMed ID: 17363609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I trial of intratumoral PVSRIPO in patients with unresectable, treatment-refractory melanoma.
    Beasley GM; Nair SK; Farrow NE; Landa K; Selim MA; Wiggs CA; Jung SH; Bigner DD; True Kelly A; Gromeier M; Salama AK
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33875611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD155 is a putative therapeutic target in medulloblastoma.
    Li S; McLendon R; Sankey E; Kornahrens R; Lyne AM; Cavalli FMG; McKay Z; Herndon JE; Remke M; Picard D; Gromeier M; Brown M; Thompson EM
    Clin Transl Oncol; 2023 Mar; 25(3):696-705. PubMed ID: 36301489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncolytic polio virotherapy of cancer.
    Brown MC; Dobrikova EY; Dobrikov MI; Walton RW; Gemberling SL; Nair SK; Desjardins A; Sampson JH; Friedman HS; Friedman AH; Tyler DS; Bigner DD; Gromeier M
    Cancer; 2014 Nov; 120(21):3277-86. PubMed ID: 24939611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of poliovirus receptor, CD155 expression in different human colorectal cancer cell lines: Implications for poliovirus virotherapy.
    Zhand S; Hosseini SM; Tabarraei A; Moradi A; Saeidi M
    J Cancer Res Ther; 2019; 15(1):61-67. PubMed ID: 30880756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic virotherapy for human bone and soft tissue sarcomas using live attenuated poliovirus.
    Atsumi S; Matsumine A; Toyoda H; Niimi R; Iino T; Nakamura T; Matsubara T; Asanuma K; Komada Y; Uchida A; Sudo A
    Int J Oncol; 2012 Sep; 41(3):893-902. PubMed ID: 22692919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intergeneric poliovirus recombinants for the treatment of malignant glioma.
    Gromeier M; Lachmann S; Rosenfeld MR; Gutin PH; Wimmer E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6803-8. PubMed ID: 10841575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of the conditionally replicative adenovirus Ad5-Delta24RGD in the treatment of malignant gliomas and its enhanced effect with radiotherapy.
    Lamfers ML; Grill J; Dirven CM; Van Beusechem VW; Geoerger B; Van Den Berg J; Alemany R; Fueyo J; Curiel DT; Vassal G; Pinedo HM; Vandertop WP; Gerritsen WR
    Cancer Res; 2002 Oct; 62(20):5736-42. PubMed ID: 12384532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of IRES-mediated, cell-type-specific cytotoxicity of poliovirus using a colorimetric cell proliferation assay.
    Yang X; Chen E; Jiang H; Muszynski K; Harris RD; Giardina SL; Gromeier M; Mitra G; Soman G
    J Virol Methods; 2009 Jan; 155(1):44-54. PubMed ID: 18951922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.